Related Experiment Video
Updated: May 4, 2026

Seizure Activity Induced by Electroshock in Drosophila Larvae
Published on: June 6, 2025
Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report
Indira Valadê Carvalho1, Renata Cavalcanti Carnevale, Marília Berlofa Visacri
1Department of Clinical Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Insights
Pediatric phenytoin toxicity occurred in a 12-year-old due to a drug interaction with valproic acid. This interaction increased free phenytoin levels, causing toxicity despite appropriate dosing.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Pharmacogenetics
Background:
- Limited published data exists on phenytoin toxicity in pediatric patients.
- Phenytoin is a commonly used antiepileptic drug, necessitating understanding of its interactions.
Observation:
- A 12-year-old with refractory epilepsy developed phenytoin toxicity.
- The patient was receiving concurrent treatment with phenytoin, valproic acid, and lamotrigine.
- Serum phenytoin levels were supratherapeutic (21.92 µg/mL) despite appropriate capsule concentration and dosage.
Findings:
- Phenytoin toxicity was observed despite appropriate drug formulation and dosage.
- Valproic acid is implicated in increasing free phenytoin serum concentrations.
- The mechanism involves displacement of phenytoin from plasma proteins and inhibition of its metabolism.
Implications:
- Highlights a critical drug interaction between valproic acid and phenytoin in pediatric epilepsy management.
- Underscores the importance of therapeutic drug monitoring for phenytoin, especially when co-administered with valproic acid.
- Suggests potential for dose adjustments or alternative antiepileptic strategies in such cases.
Introduction:
There are no published reports on pediatric phenytoin toxicity, resulting from the drug interaction between phenytoin and valproic acid.
Case Description:
A 12-year-old patient with refractory epilepsy syndrome presented with phenytoin toxicity, following a concomitant treatment with phenytoin, valproic acid, and lamotrigine. The phenytoin concentration detected in the capsules used by the patient was in accordance with the prescribed dose and was appropriate for the age and weight of the patient. However, a supratherapeutic phenytoin serum concentration was observed (21.92 µg phenytoin/mL of blood). Consequently, the phenytoin dose was reduced, and the patient was monitored; 24 hours later the patient did not present with any signs/symptoms of toxicity.
Discussion:
Despite the appropriate phenytoin concentration in the capsules, the patient presented with phenytoin toxicity. This toxicity likely resulted from the drug interaction between phenytoin and valproic acid that leads to phenytoin displacement from plasmatic proteins and inhibits phenytoin metabolism, thereby increasing the concentration of free drug in the serum.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists